Dravet syndrome treatment market size to increase by USD 575.14 million; North America to contribute 38% of market growth - Technavio

NEW YORK, Jan. 17, 2023 /PRNewswire/ -- The Dravet Syndrome Treatment Market by Product, Distribution Channel, and Geography - Forecast and Analysis 2023-2027 report has been published by Technavio. Market size is forecast to grow by USD 575.14 million between 2022 and 2027 at a CAGR of 9.6%. The report provides a comprehensive analysis of growth opportunities at regional levels, new product launches, the latest trends, and the post-pandemic recovery of the global market. Download A PDF Sample Report

Regional Analysis

By region, the global Dravet syndrome treatment market is segmented into North America, Europe, Asia, and Rest of World. North America is estimated to contribute 38% to the growth of the global market over the forecast period. The regional market is primarily driven by increasing initiatives and funding by various organizations to support the development of new treatments for DS. In addition, the presence of established medical facilities and the increasing healthcare spending by individuals are driving the growth of the Dravet syndrome treatment market in North America. Buy the report

Company Profiles

The Dravet syndrome treatment market report includes information on the key products and recent developments of leading vendors, including:

• AbbVie Inc. - The company offers Dravet syndrome treatment in the form of single dose injection vial 5mL named Depacon Valproic acid.
• BIOCODEX SAS - The company offers Dravet syndrome treatment named DIACOMIT stiripentol for children of 6 months of age and older and weighing 7 kg or more.
• Encoded Therapeutics Inc. - The company offers Dravet syndrome treatment called ETX101, which is SCN1A specific transcription factor or eTFSCN1A to upregulate or increase the expression of the endogenous SCN1A gene in human bodies.
• Epygenix Therapeutics Inc. - The company offers Dravet syndrome treatment named Clemizole, also known as EPX 100, for both adult and children.

Market Dynamics

The market is driven by factors such as the growth in special regulatory designations, increasing new product launches, and advancements in genetic therapeutics for DS treatment. However, low awareness is hindering market growth.

Competitive Analysis

The competitive scenario categorizes companies based on various performance indicators. Some of the factors considered include the financial performance of companies over the past few years, growth strategies, product innovations, new product launches, investments, and growth in market share among others. Request a Sample

Market Segmentation

• By product, the market is segmented into SDGs, TGDs, and FGDs. The SDGs segment accounted for the largest share of the market in 2022.
• By geography, the market is segmented into North America, Europe, Asia, and Rest of World. North America held the largest share of the market in 2022.

Related Reports:

• The endocrinology drugs market is estimated to grow at a CAGR of 7.82% between 2022 and 2027. The size of the market is forecast to increase by USD 36,551.24 million. The increase in the incidence of endocrine disorders is notably driving the endocrinology drugs market growth, although factors such as the patent expiry on major endocrinology drugs may impede the market growth.
• The Lennox-Gastaut Syndrome (LGS) treatment market share is expected to increase by USD 684.75 million from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 4.42%. The rising population with risk factors for LGS is notably driving the Lennox-Gastaut Syndrome treatment market growth, although factors such as difficulty in diagnosing LGS may impede the market growth.

Technavio's library includes over 17,000+ reports, covering more than 2,000 emerging technologies. Subscribe to our "Basic Plan" at just USD 5,000 and get lifetime access to Technavio Insights

What are the key data covered in this Dravet syndrome treatment market report?

• CAGR of the market during the forecast period.
• Detailed information on factors that will drive the growth of the market between 2023 and 2027
• Precise estimation of the size of the Dravet syndrome treatment market and its contribution to the parent market.
• Accurate predictions about upcoming trends and changes in consumer behavior.
• Growth of the market across North America, Europe, Asia, and Rest of World.
• A thorough analysis of the market's competitive landscape and detailed information about vendors.
• Comprehensive analysis of factors that will challenge the growth of Dravet syndrome treatment market vendors.

Table of Contents:

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary – Chart on Market Overview
• Exhibit 02: Executive Summary – Data Table on Market Overview
• Exhibit 03: Executive Summary – Chart on Global Market Characteristics
• Exhibit 04: Executive Summary – Chart on Market by Geography
• Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
• Exhibit 06: Executive Summary – Chart on Market Segmentation by Distribution Channel
• Exhibit 07: Executive Summary – Chart on Incremental Growth
• Exhibit 08: Executive Summary – Data Table on Incremental Growth
• Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition

• 3.2 Market segment analysis 
• Exhibit 13: Market segments

• 3.3 Market size 2022

• 3.4 Market outlook: Forecast for 2022-2027 
• Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global Dravet syndrome treatment market 2017 - 2021 
• Exhibit 18: Historic Market Size – Data Table on Global Dravet syndrome treatment market 2017 - 2021 ($ million)

• 4.2 Product Segment Analysis 2017 - 2021 
• Exhibit 19: Historic Market Size – Product Segment 2017 - 2021 ($ million)

• 4.3 Distribution channel Segment Analysis 2017 - 2021 
• Exhibit 20: Historic Market Size – Distribution channel Segment 2017 - 2021 ($ million)

• 4.4 Geography Segment Analysis 2017 - 2021 
• Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)

• 4.5 Country Segment Analysis 2017 - 2021 
• Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2022 and 2027

• 5.2 Bargaining power of buyers 
• Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027

• 5.3 Bargaining power of suppliers 
• Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027

• 5.4 Threat of new entrants 
• Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027

• 5.5 Threat of substitutes 
• Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027

• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027

• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Product

• 6.1 Market segments
• Exhibit 30: Chart on Product - Market share 2022-2027 (%)
• Exhibit 31: Data Table on Product - Market share 2022-2027 (%)

• 6.2 Comparison by Product 
• Exhibit 32: Chart on Comparison by Product
• Exhibit 33: Data Table on Comparison by Product

• 6.3 SGDs - Market size and forecast 2022-2027 
• Exhibit 34: Chart on SGDs - Market size and forecast 2022-2027 ($ million)
• Exhibit 35: Data Table on SGDs - Market size and forecast 2022-2027 ($ million)
• Exhibit 36: Chart on SGDs - Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on SGDs - Year-over-year growth 2022-2027 (%)

• 6.4 TGDs - Market size and forecast 2022-2027 
• Exhibit 38: Chart on TGDs - Market size and forecast 2022-2027 ($ million)
• Exhibit 39: Data Table on TGDs - Market size and forecast 2022-2027 ($ million)
• Exhibit 40: Chart on TGDs - Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on TGDs - Year-over-year growth 2022-2027 (%)

• 6.5 FDGs - Market size and forecast 2022-2027 
• Exhibit 42: Chart on FDGs - Market size and forecast 2022-2027 ($ million)
• Exhibit 43: Data Table on FDGs - Market size and forecast 2022-2027 ($ million)
• Exhibit 44: Chart on FDGs - Year-over-year growth 2022-2027 (%)
• Exhibit 45: Data Table on FDGs - Year-over-year growth 2022-2027 (%)

• 6.6 Market opportunity by Product 
• Exhibit 46: Market opportunity by Product ($ million)

7 Market Segmentation by Distribution Channel

• 7.1 Market segments
• Exhibit 47: Chart on Distribution Channel - Market share 2022-2027 (%)
• Exhibit 48: Data Table on Distribution Channel - Market share 2022-2027 (%)

• 7.2 Comparison by Distribution Channel 
• Exhibit 49: Chart on Comparison by Distribution Channel
• Exhibit 50: Data Table on Comparison by Distribution Channel

• 7.3 Hospital pharmacy - Market size and forecast 2022-2027 
• Exhibit 51: Chart on Hospital pharmacy - Market size and forecast 2022-2027 ($ million)
• Exhibit 52: Data Table on Hospital pharmacy - Market size and forecast 2022-2027 ($ million)
• Exhibit 53: Chart on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
• Exhibit 54: Data Table on Hospital pharmacy - Year-over-year growth 2022-2027 (%)

• 7.4 Retail pharmacy - Market size and forecast 2022-2027 
• Exhibit 55: Chart on Retail pharmacy - Market size and forecast 2022-2027 ($ million)
• Exhibit 56: Data Table on Retail pharmacy - Market size and forecast 2022-2027 ($ million)
• Exhibit 57: Chart on Retail pharmacy - Year-over-year growth 2022-2027 (%)
• Exhibit 58: Data Table on Retail pharmacy - Year-over-year growth 2022-2027 (%)

• 7.5 E- Commerce - Market size and forecast 2022-2027 
• Exhibit 59: Chart on E- Commerce - Market size and forecast 2022-2027 ($ million)
• Exhibit 60: Data Table on E- Commerce - Market size and forecast 2022-2027 ($ million)
• Exhibit 61: Chart on E- Commerce - Year-over-year growth 2022-2027 (%)
• Exhibit 62: Data Table on E- Commerce - Year-over-year growth 2022-2027 (%)

• 7.6 Others - Market size and forecast 2022-2027 
• Exhibit 63: Chart on Others - Market size and forecast 2022-2027 ($ million)
• Exhibit 64: Data Table on Others - Market size and forecast 2022-2027 ($ million)
• Exhibit 65: Chart on Others - Year-over-year growth 2022-2027 (%)
• Exhibit 66: Data Table on Others - Year-over-year growth 2022-2027 (%)

• 7.7 Market opportunity by Distribution Channel 
• Exhibit 67: Market opportunity by Distribution Channel ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview 
• Exhibit 68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation 
• Exhibit 69: Chart on Market share by geography 2022-2027 (%)
• Exhibit 70: Data Table on Market share by geography 2022-2027 (%)

• 9.2 Geographic comparison 
• Exhibit 71: Chart on Geographic comparison
• Exhibit 72: Data Table on Geographic comparison

• 9.3 North America - Market size and forecast 2022-2027 
• Exhibit 73: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 74: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 75: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibit 76: Data Table on North America - Year-over-year growth 2022-2027 (%)

• 9.4 Europe - Market size and forecast 2022-2027 
• Exhibit 77: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 78: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 79: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibit 80: Data Table on Europe - Year-over-year growth 2022-2027 (%)

• 9.5 Asia - Market size and forecast 2022-2027 
• Exhibit 81: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 82: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 83: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibit 84: Data Table on Asia - Year-over-year growth 2022-2027 (%)

• 9.6 Rest of World (ROW) - Market size and forecast 2022-2027 
• Exhibit 85: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 86: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 87: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibit 88: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)

• 9.7 US - Market size and forecast 2022-2027 
• Exhibit 89: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 90: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 91: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibit 92: Data Table on US - Year-over-year growth 2022-2027 (%)

• 9.8 UK - Market size and forecast 2022-2027 
• Exhibit 93: Chart on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 94: Data Table on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 95: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibit 96: Data Table on UK - Year-over-year growth 2022-2027 (%)

• 9.9 Germany - Market size and forecast 2022-2027 
• Exhibit 97: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 98: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 99: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibit 100: Data Table on Germany - Year-over-year growth 2022-2027 (%)

• 9.10 China - Market size and forecast 2022-2027 
• Exhibit 101: Chart on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 102: Data Table on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 103: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibit 104: Data Table on China - Year-over-year growth 2022-2027 (%)

• 9.11 Japan - Market size and forecast 2022-2027 
• Exhibit 105: Chart on Japan - Market size and forecast 2022-2027 ($ million)
• Exhibit 106: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
• Exhibit 107: Chart on Japan - Year-over-year growth 2022-2027 (%)
• Exhibit 108: Data Table on Japan - Year-over-year growth 2022-2027 (%)

• 9.12 Market opportunity by geography 
• Exhibit 109: Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers

• 10.2 Market challenges

• 10.3 Impact of drivers and challenges 
• Exhibit 110: Impact of drivers and challenges in 2022 and 2027

• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview

• 11.2 Vendor landscape
• Exhibit 111: Overview on Criticality of inputs and Factors of differentiation

• 11.3 Landscape disruption
• Exhibit 112: Overview on factors of disruption

• 11.4 Industry risks
• Exhibit 113: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 114: Vendors covered

• 12.2 Market positioning of vendors 
• Exhibit 115: Matrix on vendor position and classification

• 12.3 AbbVie Inc.
• Exhibit 116: AbbVie Inc. - Overview
• Exhibit 117: AbbVie Inc. - Product / Service
• Exhibit 118: AbbVie Inc. - Key news
• Exhibit 119: AbbVie Inc. - Key offerings

• 12.4 BIOCODEX SAS
• Exhibit 120: BIOCODEX SAS - Overview
• Exhibit 121: BIOCODEX SAS - Product / Service
• Exhibit 122: BIOCODEX SAS - Key offerings

• 12.5 Encoded Therapeutics Inc. 
• Exhibit 123: Encoded Therapeutics Inc. - Overview
• Exhibit 124: Encoded Therapeutics Inc. - Product / Service
• Exhibit 125: Encoded Therapeutics Inc. - Key offerings

• 12.6 Epygenix Therapeutics Inc. 
• Exhibit 126: Epygenix Therapeutics Inc. - Overview
• Exhibit 127: Epygenix Therapeutics Inc. - Product / Service
• Exhibit 128: Epygenix Therapeutics Inc. - Key offerings

• 12.7 H Lundbeck AS
• Exhibit 129: H Lundbeck AS - Overview
• Exhibit 130: H Lundbeck AS - Product / Service
• Exhibit 131: H Lundbeck AS - Key offerings

• 12.8 Jazz Pharmaceuticals Plc 
• Exhibit 132: Jazz Pharmaceuticals Plc - Overview
• Exhibit 133: Jazz Pharmaceuticals Plc - Product / Service
• Exhibit 134: Jazz Pharmaceuticals Plc - Key news
• Exhibit 135: Jazz Pharmaceuticals Plc - Key offerings

• 12.9 Johnson and Johnson
• Exhibit 136: Johnson and Johnson - Overview
• Exhibit 137: Johnson and Johnson - Business segments
• Exhibit 138: Johnson and Johnson - Key news
• Exhibit 139: Johnson and Johnson - Key offerings
• Exhibit 140: Johnson and Johnson - Segment focus

• 12.10 Lupin Ltd.
• Exhibit 141: Lupin Ltd. - Overview
• Exhibit 142: Lupin Ltd. - Product / Service
• Exhibit 143: Lupin Ltd. - Key news
• Exhibit 144: Lupin Ltd. - Key offerings

• 12.11 PTC Therapeutics Inc. 
• Exhibit 145: PTC Therapeutics Inc. - Overview
• Exhibit 146: PTC Therapeutics Inc. - Business segments
• Exhibit 147: PTC Therapeutics Inc. - Key offerings
• Exhibit 148: PTC Therapeutics Inc. - Segment focus

• 12.12 Stoke Therapeutics Inc. 
• Exhibit 149: Stoke Therapeutics Inc. - Overview
• Exhibit 150: Stoke Therapeutics Inc. - Product / Service
• Exhibit 151: Stoke Therapeutics Inc. - Key offerings

• 12.13 Sun Pharmaceutical Industries Ltd. 
• Exhibit 152: Sun Pharmaceutical Industries Ltd. - Overview
• Exhibit 153: Sun Pharmaceutical Industries Ltd. - Product / Service
• Exhibit 154: Sun Pharmaceutical Industries Ltd. - Key offerings

• 12.14 Supernus Pharmaceuticals Inc. 
• Exhibit 155: Supernus Pharmaceuticals Inc. - Overview
• Exhibit 156: Supernus Pharmaceuticals Inc. - Product / Service
• Exhibit 157: Supernus Pharmaceuticals Inc. - Key offerings

• 12.15 Takeda Pharmaceutical Co. Ltd. 
• Exhibit 158: Takeda Pharmaceutical Co. Ltd. - Overview
• Exhibit 159: Takeda Pharmaceutical Co. Ltd. - Product / Service
• Exhibit 160: Takeda Pharmaceutical Co. Ltd. - Key news
• Exhibit 161: Takeda Pharmaceutical Co. Ltd. - Key offerings

• 12.16 UCB SA
• Exhibit 162: UCB SA - Overview
• Exhibit 163: UCB SA - Product / Service
• Exhibit 164: UCB SA - Key offerings

• 12.17 Viatris Inc.
• Exhibit 165: Viatris Inc. - Overview
• Exhibit 166: Viatris Inc. - Business segments
• Exhibit 167: Viatris Inc. - Key offerings
• Exhibit 168: Viatris Inc. - Segment focus

13 Appendix

• 13.1 Scope of the report

• 13.2 Inclusions and exclusions checklist 
• Exhibit 169: Inclusions checklist
• Exhibit 170: Exclusions checklist

• 13.3 Currency conversion rates for US$ 
• Exhibit 171: Currency conversion rates for US$

• 13.4 Research methodology
• Exhibit 172: Research methodology
• Exhibit 173: Validation techniques employed for market sizing
• Exhibit 174: Information sources

• 13.5 List of abbreviations 
• Exhibit 175: List of abbreviations

About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio